Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PAD vs TAD in Newly Diagnosed Multiple Myeloma
NCT01249690Phase 4Unknown
- Sponsor
- Naval Medical University
- Start
- Jun 2010
- Primary completion
- Jun 2012
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of bortezomib, thalidomide in multiple myeloma (MM), sponsored by Naval Medical University. Status: unknown.
02
Drugs
bortezomibthalidomide
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT01249690.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01249690.